XB-ART-1543J Med Genet. October 7, 2005; 280 (40): 34218-23.
WNK1 (with no lysine (K) 1) is a protein-serine/threonine kinase with a unique catalytic site organization. Deletions in the first intron of the WNK1 gene were found in a group of hypertensive patients with pseudohypoaldosteronism type II. No changes in coding sequence of WNK1 were found, but its expression was increased severalfold. We have been investigating actions of WNK1 and have found that WNK1 activates the serum- and glucocorticoid-induced protein kinase SGK1, which impacts membrane expression of the epithelial sodium channel. Here we explore the role of WNK1 in SGK1 regulation. Activation of SGK1 by WNK1 is blocked by phosphatidylinositol 3-kinase inhibitors. Neither the catalytic activity nor the kinase domain of WNK1 is required; rather the N-terminal 220 residues of WNK1 are necessary and sufficient to activate SGK1. Phosphorylation of WNK1 on Thr-58 contributes to SGK1 activation. Finally, we show that WNK1 is required for the activation of SGK1 by insulin-like growth factor 1.
PubMed ID: 16081417
Article link: J Med Genet.
Grant support: DK54368 NIDDK NIH HHS , DK59530 NIDDK NIH HHS , GM53032 NIGMS NIH HHS , DK54368 NIDDK NIH HHS , DK59530 NIDDK NIH HHS , GM53032 NIGMS NIH HHS
Genes referenced: ins sgk1 wnk1